Timber Hill LLC purchased a new position in Agilent Technologies, Inc. (NYSE:A) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 26,042 shares of the medical research company’s stock, valued at approximately $1,672,000.
A number of other institutional investors have also bought and sold shares of the business. Dupont Capital Management Corp acquired a new position in Agilent Technologies in the 3rd quarter worth approximately $101,000. Balentine LLC boosted its stake in Agilent Technologies by 2.9% in the 2nd quarter. Balentine LLC now owns 1,794 shares of the medical research company’s stock worth $106,000 after purchasing an additional 50 shares during the period. Sun Life Financial INC boosted its stake in Agilent Technologies by 26,144.4% in the 2nd quarter. Sun Life Financial INC now owns 2,362 shares of the medical research company’s stock worth $140,000 after purchasing an additional 2,353 shares during the period. Acrospire Investment Management LLC boosted its stake in Agilent Technologies by 92.3% in the 2nd quarter. Acrospire Investment Management LLC now owns 2,500 shares of the medical research company’s stock worth $148,000 after purchasing an additional 1,200 shares during the period. Finally, Parallel Advisors LLC boosted its stake in Agilent Technologies by 5.3% in the 2nd quarter. Parallel Advisors LLC now owns 2,623 shares of the medical research company’s stock worth $157,000 after purchasing an additional 131 shares during the period.
A number of brokerages have issued reports on A. Barclays PLC reissued a “buy” rating and set a $67.00 target price on shares of Agilent Technologies in a research note on Wednesday, July 19th. BidaskClub lowered shares of Agilent Technologies from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 31st. Jefferies Group LLC restated a “buy” rating and set a $66.00 price target on shares of Agilent Technologies in a report on Wednesday, August 9th. J P Morgan Chase & Co restated an “overweight” rating and set a $70.00 price target on shares of Agilent Technologies in a report on Wednesday, August 16th. Finally, Bank of America Corporation restated an “equal weight” rating on shares of Agilent Technologies in a report on Tuesday, August 15th. Five research analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $66.70.
Agilent Technologies, Inc. (A) traded down $0.15 during trading hours on Thursday, hitting $67.31. 2,042,200 shares of the stock traded hands, compared to its average volume of 1,824,496. Agilent Technologies, Inc. has a one year low of $42.92 and a one year high of $68.67. The company has a debt-to-equity ratio of 0.39, a quick ratio of 2.76 and a current ratio of 3.22. The company has a market cap of $21,710.52, a P/E ratio of 29.46, a price-to-earnings-growth ratio of 2.64 and a beta of 1.27.
Agilent Technologies (NYSE:A) last issued its earnings results on Tuesday, August 15th. The medical research company reported $0.59 earnings per share for the quarter, beating the consensus estimate of $0.52 by $0.07. Agilent Technologies had a net margin of 14.36% and a return on equity of 16.95%. The business had revenue of $1.11 billion for the quarter, compared to analyst estimates of $1.09 billion. During the same period in the previous year, the business earned $0.49 EPS. The firm’s revenue was up 6.7% on a year-over-year basis. research analysts forecast that Agilent Technologies, Inc. will post 2.32 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 24th. Stockholders of record on Tuesday, January 2nd will be given a dividend of $0.149 per share. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.13. This represents a $0.60 annualized dividend and a dividend yield of 0.89%. Agilent Technologies’s payout ratio is 27.32%.
In other Agilent Technologies news, CFO Didier Hirsch sold 1,200 shares of the business’s stock in a transaction dated Wednesday, September 13th. The shares were sold at an average price of $66.00, for a total value of $79,200.00. Following the transaction, the chief financial officer now directly owns 164,202 shares in the company, valued at $10,837,332. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, insider Mark Doak sold 12,421 shares of the business’s stock in a transaction dated Friday, August 18th. The shares were sold at an average price of $61.57, for a total transaction of $764,760.97. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 152,713 shares of company stock worth $9,682,305.
Agilent Technologies Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.